Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion type Assertion NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_head.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion description "[The H63D homozygote mutation was identified in 7.76% of the control group, in 7.50% of the PH group, and in 11.11% of patients with PCT (P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_provenance.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion evidence source_evidence_literature NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_provenance.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion SIO_000772 20594259 NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_provenance.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion wasDerivedFrom gad-20150221 NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_provenance.
- NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_assertion wasGeneratedBy ECO_0000203 NP50111.RAmtv1Ni-tWVEWuAFMR9KWWvVxulvNkfAGdVfNfxcpY0U130_provenance.